Isomorphic Labs just closed a two point one dollars billion Series B. No approved drug. No Phase two human data publicly reported. The entire price tag is a platform thesis.
What makes this round genuinely interesting is not the headline number. It is who is on the cap table and who is not.
The UK Sovereign AI Fund joined. So did MGX from Abu Dhabi and Te…
